Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-24 | New | $1,430,000 | $1,430,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Ranjit Bindra | Director |
| Michael Dillon | Director |
| Kevin L. Rakin | Director, Executive |